<code id='96BEAA8DA1'></code><style id='96BEAA8DA1'></style>
    • <acronym id='96BEAA8DA1'></acronym>
      <center id='96BEAA8DA1'><center id='96BEAA8DA1'><tfoot id='96BEAA8DA1'></tfoot></center><abbr id='96BEAA8DA1'><dir id='96BEAA8DA1'><tfoot id='96BEAA8DA1'></tfoot><noframes id='96BEAA8DA1'>

    • <optgroup id='96BEAA8DA1'><strike id='96BEAA8DA1'><sup id='96BEAA8DA1'></sup></strike><code id='96BEAA8DA1'></code></optgroup>
        1. <b id='96BEAA8DA1'><label id='96BEAA8DA1'><select id='96BEAA8DA1'><dt id='96BEAA8DA1'><span id='96BEAA8DA1'></span></dt></select></label></b><u id='96BEAA8DA1'></u>
          <i id='96BEAA8DA1'><strike id='96BEAA8DA1'><tt id='96BEAA8DA1'><pre id='96BEAA8DA1'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:1
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Listen: More tumult at BIO & coercive care for sickle cell patients
          Listen: More tumult at BIO & coercive care for sickle cell patients

          Howdoesadrugindustrylobbyinggroupmoveforwardafteryearsofupheaval,includinghavingfourCEOsinfouryears?

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Fentanyl is making it harder to start addiction treatment

          PacketsofbuprenorphineEliseAmendola/APDoctorsarereportingatroublingtrendwhenitcomestofentanyl.Thepow